CAH:NYE-Cardinal Health Inc. (USD)

EQUITY | Medical Distribution | New York Stock Exchange

Last Closing

USD 103.54

Change

+0.17 (+0.16)%

Market Cap

USD 22.38B

Volume

2.06M

Analyst Target

USD 58.94
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Cardinal Health Inc is a healthcare services company. It provides healthcare services and products for hospital systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices. Its segments are pharmaceutical and medical.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-24 )

Largest Industry Peers for Medical Distribution

Symbol Name Price(Change) Market Cap
MCK McKesson Corporation

N/A

USD 70.80B
COR Cencora Inc.

N/A

USD 38.52B
OMI Owens & Minor Inc

N/A

USD 2.06B
NVG Nuveen AMT Free Municipal Cred..

N/A

USD 3.29M

ETFs Containing CAH

VALQ American Century STOXX U... 2.28 % 0.29 %

N/A

USD 0.21B
IQSA:LSE Invesco Quantitative Stra.. 1.68 % 0.00 %

N/A

USD 0.24B
DEF 0.00 % 0.59 %

N/A

N/A
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

N/A

USD 5.46M
FHH:CA First Trust AlphaDEX US H.. 0.00 % 0.77 %

N/A

CAD 0.01B
FXH First Trust Health Care A.. 0.00 % 0.63 %

N/A

USD 1.33B
IBDD 0.00 % 0.10 %

N/A

N/A
ONEO SPDR® Russell 1000 Momen.. 0.00 % 0.20 %

N/A

USD 0.14B
ONEV SPDR® Russell 1000 Low V.. 0.00 % 0.20 %

N/A

USD 0.62B
ONEY SPDR® Russell 1000® Yie.. 0.00 % 0.20 %

N/A

USD 0.78B
PWC 0.00 % 0.59 %

N/A

N/A
QSY 0.00 % 0.38 %

N/A

N/A
FTXH First Trust Nasdaq Pharma.. 0.00 % 0.60 %

N/A

USD 0.02B
IVFVC 0.00 % 0.00 %

N/A

N/A
UTRN Vesper U.S. Large Cap Sho.. 0.00 % 0.00 %

N/A

USD 0.02B
DBLV 0.00 % 0.87 %

N/A

N/A
GBDV 0.00 % 0.00 %

N/A

N/A
IQSA:XETRA Invesco Quantitative Stra.. 0.00 % 0.00 %

N/A

USD 0.07B
IQSE:XETRA Invesco Quantitative Stra.. 0.00 % 0.00 %

N/A

USD 0.05B
FHH-F:CA First Trust AlphaDEX U.S... 0.00 % 0.00 %

N/A

CAD 0.01B

Market Performance

  Market Performance vs. Industry/Classification (Medical Distribution) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.72% 40% F 59% D-
Dividend Return 0.50% 75% C 29% F
Total Return 3.21% 40% F 56% F
Trailing 12 Months  
Capital Gain 28.80% 40% F 82% B
Dividend Return 2.49% 75% C 36% F
Total Return 31.29% 40% F 81% B-
Trailing 5 Years  
Capital Gain 117.93% 60% D- 90% A-
Dividend Return 20.66% 80% B- 74% C
Total Return 138.59% 60% D- 90% A-
Average Annual (5 Year Horizon)  
Capital Gain 20.41% 67% D+ 85% B
Dividend Return 23.96% 67% D+ 86% B+
Total Return 3.55% 67% D+ 67% D+
Risk Return Profile  
Volatility (Standard Deviation) 22.80% 50% F 50% F
Risk Adjusted Return 105.10% 67% D+ 99% N/A
Market Capitalization 22.38B 60% D- 91% A-

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Distribution) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 17.00 20% 14%
Price/Book Ratio 16.07 33% 4%
Price / Cash Flow Ratio 9.27 75% 40%
Price/Free Cash Flow Ratio 13.58 50% 29%
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital 10.87% 50% 67%
Return on Assets 2.79% 60% 54%
Debt to Equity Ratio -137.11% 75% 96%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced on cashflow basis

The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector